1Celli BR,Macnee W,Agusti A,et a1.Standards for the diagnosis andtreatment of patients with COPD:a summary of the ATS/ERS posi-tion paper[J].Eur Respir J,2004,23:932-946. 被引量：1
4Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med, 2006,173:707-717. 被引量：1
5Pittet D, Huguenin T, Dharan S, et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1996, 154:541- 544. 被引量：1
6Rello J, Esandi ME, Mariscal D, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis, 1998, 26 : 1473-1475. 被引量：1
7Bulpa PA, Dive AM, Garrino MG, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med, 2001, 27:59-67. 被引量：1
8Ader F, Nseir S, Le Berre R, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect, 2005, 11:427-429. 被引量：1
9Muquim A, Dial S, Menzies D. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can Respir J, 2005, 12 : 199-204. 被引量：1
10Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Meal, 2004, 170:580-581. 被引量：1
4Mansori F,Nemat KA,Boskabady MH,et al.The effect of inhaled salmeterol,alone and in combination with flutica- sone propionate on management of COPD patients [J].Clin Respir,2010,4(4) :241-247. 被引量：1
5Dalal AA, Candrilli SD, Davis KL. Outcomes and costs associated with initial maintenance therapy with flutica-sone propionate-salmeterol xinafoate 250 microg/50 microg combination versus tiotropium in commercially insured patients with COPD. Manag Care, 2011,20 (8) : 46-50. 被引量：1
